These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24040195)

  • 1. Aspirin and low-molecular weight heparin combination therapy effectively prevents recurrent miscarriage in hyperhomocysteinemic women.
    Chakraborty P; Banerjee S; Saha P; Nandi SS; Sharma S; Goswami SK; Chakravarty B; Kabir SN
    PLoS One; 2013; 8(9):e74155. PubMed ID: 24040195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent pregnancy loss in polycystic ovary syndrome: role of hyperhomocysteinemia and insulin resistance.
    Chakraborty P; Goswami SK; Rajani S; Sharma S; Kabir SN; Chakravarty B; Jana K
    PLoS One; 2013; 8(5):e64446. PubMed ID: 23700477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
    Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin, low molecular weight heparin, or both in preventing pregnancy complications in women with recurrent pregnancy loss and factor V Leiden mutation.
    Karadağ C; Akar B; Gönenç G; Aslancan R; Yılmaz N; Çalışkan E
    J Matern Fetal Neonatal Med; 2020 Jun; 33(11):1934-1939. PubMed ID: 31550962
    [No Abstract]   [Full Text] [Related]  

  • 5. CORRELATION BETWEEN LEVELS OF HOMOCYSTEINE, ANTI-MÜLLERIAN HORMONE AND INSULIN RESISTANCE IN PCOS PATIENTS WITH RECURRENT MISCARRIAGE.
    Asanidze E; Kristesashvili J; Andguladze S
    Georgian Med News; 2019 May; (290):25-29. PubMed ID: 31322509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials.
    Areia AL; Fonseca E; Areia M; Moura P
    Arch Gynecol Obstet; 2016 Jan; 293(1):81-86. PubMed ID: 26059084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.
    Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004734. PubMed ID: 19160241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low molecular weight heparin or LMWH plus aspirin in the treatment of unexplained recurrent miscarriage with negative antiphospholipid antibodies: A meta-analysis of randomized controlled trial.
    Yan X; Wang D; Yan P; Li H
    Eur J Obstet Gynecol Reprod Biol; 2022 Jan; 268():22-30. PubMed ID: 34794071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a meta-analysis of randomized controlled trials.
    Lu C; Liu Y; Jiang HL
    J Matern Fetal Neonatal Med; 2019 Apr; 32(8):1299-1311. PubMed ID: 29179589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of heparin in women with early and late miscarriages with and without thrombophilia.
    Monien S; Kadecki O; Baumgarten S; Salama A; Dörner T; Kiesewetter H
    Clin Appl Thromb Hemost; 2009 Dec; 15(6):636-44. PubMed ID: 19666941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, controlled clinical study of low-molecular-weight heparin improving pregnancy outcomes in PCOS women undergoing IVF: study protocol.
    Huang O; Ding H; Wu D; Zhang Q; Li W
    Trials; 2024 Jan; 25(1):16. PubMed ID: 38167499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of Hyperhomocysteinemia in Immediate As Well As Long-Term Health Risk/s in Women with Polycystic Ovary Syndrome: a Probabilistic Model Using Dynamic Bayesian Network Analysis.
    Chakraborty P; Mitra I; Kalapahar S; Sharma S; Chattopadhyay R; Chakravarty B
    Reprod Sci; 2023 Apr; 30(4):1207-1216. PubMed ID: 35802293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-molecular-weight heparin in the prevention of unexplained recurrent miscarriage: a systematic review and meta-analysis.
    Scarrone M; Salmeri N; Buzzaccarini G; Canti V; Pasi F; Papaleo E; Rovere-Querini P; Candiani M; Alteri A; Busnelli A; Vanni VS
    Sci Rep; 2024 Jun; 14(1):14168. PubMed ID: 38898143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of D-dimer measurement to guide anticoagulant treatment in recurrent pregnancy loss associated with antiphospholipid syndrome.
    Bao SH; Sheng SL; Liao H; Zhou Q; Frempong ST; Tu WY
    Am J Reprod Immunol; 2017 Dec; 78(6):. PubMed ID: 29024233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of recurrent miscarriage in women with antiphospholipid syndrome: A systematic review and network meta-analysis.
    Yang Z; Shen X; Zhou C; Wang M; Liu Y; Zhou L
    Lupus; 2021 Jan; 30(1):70-79. PubMed ID: 33081590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Findings from a multicentre, observational study on reproductive outcomes in women with unexplained recurrent pregnancy loss: the OTTILIA registry.
    Grandone E; Tiscia GL; Mastroianno M; Larciprete G; Kovac M; Tamborini Permunian E; Lojacono A; Barcellona D; Bitsadze V; Khizroeva J; Makatsarya A; Cacciola R; Martinelli I; Bucherini E; De Stefano V; Lodigiani C; Colaizzo D; De Laurenzo A; Piazza G; Margaglione M
    Hum Reprod; 2021 Jul; 36(8):2083-2090. PubMed ID: 34195794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin and aspirin combination therapy restores T-cell phenotype in pregnant patients with antiphospholipid syndrome-related recurrent pregnancy loss.
    Wang M; Zhang P; Yu S; Zhou G; Lv J; Nallapothula D; Guo C; Wang Q; Singh RR
    Clin Immunol; 2019 Nov; 208():108259. PubMed ID: 31513884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.
    Laskin CA; Spitzer KA; Clark CA; Crowther MR; Ginsberg JS; Hawker GA; Kingdom JC; Barrett J; Gent M
    J Rheumatol; 2009 Feb; 36(2):279-87. PubMed ID: 19208560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome.
    Fouda UM; Sayed AM; Abdou AM; Ramadan DI; Fouda IM; Zaki MM
    Int J Gynaecol Obstet; 2011 Mar; 112(3):211-5. PubMed ID: 21251653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss: a multicenter trial with a minimization randomization scheme.
    Schleussner E; Kamin G; Seliger G; Rogenhofer N; Ebner S; Toth B; Schenk M; Henes M; Bohlmann MK; Fischer T; Brosteanu O; Bauersachs R; Petroff D;
    Ann Intern Med; 2015 May; 162(9):601-9. PubMed ID: 25938990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.